Menu
Great Point Partners
  • Our Firm
    • Overview
    • Our Investors
  • Private Equity
    • Overview
    • Choosing a Financial Partner
    • Our Partnership Philosophy
    • Investment Criteria
    • Case Studies
  • Public Equity
    • Overview
    • Select Investments
  • Team
  • Private Equity Portfolio
  • News
  • Contact
We’d like to use cookies to understand your use of our website and to give you a better experience. To find out more about cookies and how to change your choices, please go to our Legal Disclosure

Investment Criteria

Home / Private Equity / Investment Criteria

We invest in growing health care companies and executive leadership capable of sustaining growth.

We invest in innovative health care companies with a demonstrated track record of both revenue and profit growth. We encourage both executives and interested intermediaries to contact a Great Point Partners professional directly about a potential investment opportunity. To learn more about the types of companies we invest in, including select case studies, click here.

Great Point Partners Investment Criteria

Health Care Industries In Which We Invest

  • Biopharmaceutical Supply Chain Services and Products
  • Health Care Services
  • Health Care Information Technology Enabled Services
  • Medical Devices and Diagnostics

Our Geographic Focus

Great Point Partners invests primarily in companies located in the United States, Canada and Western Europe.

    • Exited Investment
    • Greenville, SC
    • Clinical Trial Site Network
    • Current Investment
    • Raleigh, NC
    • Biopharmaceutical Contract Manufacturing
    • Current Investment
    • Houston, TX
    • Outsourced Surgical Assistants
    • Current Investment
    • Houston, TX
    • Contract Manufacturer of Medical Devices
    • Current Investment
    • San Antonio, TX
    • Operator of Pediatric Urgent Care Clinics
    • Current Investment
    • Hudson, OH
    • Outsourced Radiology Services
    • Exited Investment
    • Jacksonville, FL
    • Technology-enabled population health management
    • Exited Investment
    • Malvern, PA
    • Clinical Trial Supplies Management
    • Current Investment
    • Southborough, MA
    • Nationwide Provider of Post Approval Drug Registries
    • Exited Investment
    • Long Crendon, UK
    • Temperature Controlled Packaging for Pharmaceuticals
    • Exited Investment
    • Ireland
    • Contract Manufacturing of Medical Devices
    • Current Investment
    • Phoenix, AZ
    • Medical Claims Flow Management
    • Current Investment
    • Flagstaff, AZ
    • Virtual Speech Therapy and Mental Health Services
    • Exited Investment
    • Glendale, CA
    • Autism Services
    • Exited Investment
    • Fremont, CA
    • Biopharmaceutical Contract Manufacturing
    • Current Investment
    • Spokane, WA
    • Provider of Home Care Services
    • Current Investment
    • San Diego, CA
    • Physical Therapy Provider
    • Current Investment
    • San Diego, CA
    • Cell and Gene Therapy Contract Manufacturing
    • Current Investment
    • San Diego, CA
    • Services for biotechnology companies
    • Exited Investment
    • Ann Arbor, MI
    • Intra-operative Neurophysiological Monitoring
    • Exited Investment
    • Montréal, Quebec
    • Biomarker Discovery Services
    • Exited Investment
    • Brookfield, WI
    • Sales Automation & Exchange Technology
    • Current Investment
    • Toronto, Canada
    • Clinical Trial Software
      and Services
    • Exited Investment
    • Oklahoma City, OK
    • Biopharmaceutical Contract Manufacturing
    • Exited Investment
    • Indianapolis, IN
    • Outsourced Medical Cost Management
    • Exited Investment
    • Manassas, VA
    • Cell Culture Media
    • Current Investment
    • Washington, D.C.
    • Healthcare Communications & Marketing
    • Exited Investment
    • Whitestone, NY
    • Orthopedic and Sports Physical Therapy
    • Current Investment
    • Iselin, New Jersey
    • Biometrics Contract Research Organization
    • Exited Investment
    • Charleroi, Belgium
    • Cell and Gene Therapy Contract Manufacturing
    • Current Investment
    • Mönchengladbach, Germany
    • Central and Specialty Lab
    • Great Point Partners invests primarily in companies located in the United States, Canada and Western Europe.

Investment Size

We target companies that are generating between $10-100 million of revenue and $2-12 million of EBITDA. Our equity investments range from $7-$50 million.

Tuck-in Acquisitions

Great Point Partners actively sources tuck-in acquisition opportunities for our portfolio companies and have completed over 75 tuck-in acquisitions since our first investment in 2006. Tuck-in candidates generate over $1 million of revenue and are profitable. We like to invest in companies where tuck-in acquisitions can augment organic growth.

Minority vs. Majority

We are equally comfortable with minority and majority ownership investments. In fact, about 25% of our investments are minority interests.

Investment Flexibility

We offer a wide range of shareholder liquidity and ownership options – seeking to align interests between management teams and Great Point Partners. Generally, we are the first institutional investor, and always the lead investor. We structure investments that sustain long-term growth, support financial stability, and maximize shareholder value.

  • Overview
  • Choosing a Financial Partner
  • Our Partnership Philosophy
  • Investment Criteria
  • Case Studies
  • Careers
  • Investor Portal
  • Site Map

© 2023 Great Point Partners, LLC
Legal Disclosure

  • Our Firm
    • Overview
    • Our Investors
  • Private Equity
    • Overview
    • Choosing a Financial Partner
    • Our Partnership Philosophy
    • Investment Criteria
    • Case Studies
  • Public Equity
    • Overview
    • Select Investments
  • Team
  • Private Equity Portfolio
  • News
  • Contact